A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

Recruiting

Sponsor:

Jazz Pharmaceuticals

Code:

NCT05864846

Conditions

Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

Eligibility Criteria

Sex: All

Age: 1 - 65

Healthy Volunteers: Not accepted

Interventions

Cannabidiol Oral Solution [Epidiolex]

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information